121 related articles for article (PubMed ID: 4125022)
21. Malignant melanoma.
Moore GE; Gerner RE
Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
[No Abstract] [Full Text] [Related]
22. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
23. Combination chemotherapy of carboplatin and paclitaxel for metastatic melanoma.
Sato Y; Uhara H; Ashida A; Okuyama R
J Dermatol; 2013 Dec; 40(12):1050-1. PubMed ID: 24330169
[No Abstract] [Full Text] [Related]
24. The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma.
Hughes T; Klairmont M; Broucek J; Iodice G; Basu S; Kaufman HL
Cancer Immunol Immunother; 2015 Apr; 64(4):459-65. PubMed ID: 25603775
[TBL] [Abstract][Full Text] [Related]
25. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
26. [Chemotherapy of malignant melanomas].
Gallmeier WM
Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
[No Abstract] [Full Text] [Related]
27. [Present status of the melanoma problem].
Braun W; Lübbe D; Wohlrab W; Wozniak KD; Zaumseil RP
Dermatol Monatsschr; 1979 Oct; 165(10):732-40. PubMed ID: 393546
[No Abstract] [Full Text] [Related]
28. Communicating information to the general practitioner: the example of vemurafenib for metastatic melanoma.
Rougé Bugat ME; Dufossé V; Paul C; Oustric S; Meyer N
J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):e192-e194. PubMed ID: 26559518
[No Abstract] [Full Text] [Related]
29. [Immunotherapy of cancer].
Mäkelä O; Kaartinen M
Duodecim; 1973; 89(18):1257-62. PubMed ID: 4771796
[No Abstract] [Full Text] [Related]
30. Treatment of malignant melanoma with camptothecin (NSC-100880).
Gottlieb JA; Luce JK
Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802
[No Abstract] [Full Text] [Related]
31. Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma.
Amann VC; Hoffmann D; Mangana J; Dummer R; Goldinger SM
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1638-1640. PubMed ID: 28401596
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
Nathanson L; Wolter J; Horton J; Colsky J; Shnider BI; Schilling A
Clin Pharmacol Ther; 1971; 12(6):955-62. PubMed ID: 5134998
[No Abstract] [Full Text] [Related]
33. [New hope in metastatic melanoma treatment?].
Guillot B
Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
[No Abstract] [Full Text] [Related]
34. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
[No Abstract] [Full Text] [Related]
35. Letter: 2,4-Dinitrochlorobenzene therapy for plantar warts.
Greenberg J
Arch Dermatol; 1974 Jun; 109(6):910. PubMed ID: 4830106
[No Abstract] [Full Text] [Related]
36. Intralesional immunotherapy as a strategy to treat melanoma.
Nouri N; Garbe C
Expert Opin Biol Ther; 2016; 16(5):619-26. PubMed ID: 26898656
[TBL] [Abstract][Full Text] [Related]
37. [Immunotherapy of tumors: from the laboratory to the clinic].
Castermans A; Vanwijck R
Rev Med Liege; 1976 Dec; 31(24):767-8. PubMed ID: 1005982
[No Abstract] [Full Text] [Related]
38. [Melanoma: a new interferon is coming ... handle with care!].
Négrier S
Bull Cancer; 1997 Apr; 84(4):435-7. PubMed ID: 9238171
[No Abstract] [Full Text] [Related]
39. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF
Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
[No Abstract] [Full Text] [Related]
40. Chemotherapy and immunotherapy for malignant melanoma.
Richman SP; Gutterman JU; Hersh EM
Compr Ther; 1980 Oct; 6(10):57-61. PubMed ID: 7449366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
